A comprehensive view of Respiratory/Lung Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Global bronchitis treatment market projected to grow by US$1.1B, have CAGR growth of 4.76%, from 2021 to 2026; growth driven by increase in smoking, as 32.51 million people smoked in US in 2020, 3.7 million smoke in Canada: Technavio

Novartis cancels filing for FDA approval of tislelizumab to treat non-small cell lung cancer after FDA decision to delay review of drug as esophageal squamous cell carcinoma treatment; Novartis paid BeiGene US$650M for rights to drug outside China

Global respiratory monitoring devices market expected to reach US$15.0B by 2021, with 6.3% CAGR growth from 2022-2031; growth driven by increase in chronic obstructive pulmonary disease, prevalence of obstructive sleep apnea

Royalty Pharma buys royalty rights to GSK’s Trelegy Ellipta fluticasone furoate, umeclidinium, vilanterol from Theravance Respiratory for US$1.6B; Trelegy treats chronic obstructive pulmonary disease and asthma, had 2021 sales of US$1.7B

Study finds inhaled corticosteroid asthma drug fluticasone furoate not effective against mild-to-moderate COVID-19; drug was one of three repurposed drugs being tested against COVID-19: Duke Clinical Research Institute

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count